Hyperuricaemia as a prognostic factor for acute ischaemic stroke

被引:1
作者
Cabrera Naranjo, F. H. [1 ]
Saavedra Santana, P. [2 ]
Gonzalez Hernandez, A. [3 ]
Fabre Pi, O. [1 ]
Sosa-Henriquez, M. [4 ]
机构
[1] Hosp Univ Dr Negrin, Serv Neurol, Las Palmas Gran Canaria, Spain
[2] Univ Las Palmas Gran Canaria, Dept Matemat, Las Palmas Gran Canaria, Spain
[3] Hosp San Roque, Serv Neurol, Las Palmas Gran Canaria, Spain
[4] Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanitarias, Las Palmas Gran Canaria, Spain
来源
NEUROLOGIA | 2021年 / 36卷 / 04期
关键词
Stroke; Hyperuricaemia; Uric acid; Functional prognosis; Biomarkers; Functionality; SERUM URIC-ACID; INDEPENDENT PREDICTOR; HYPERTENSION; IMPROVES; DEATH; ICTUS;
D O I
10.1016/j.nrl.2018.01.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Recent studies on uric acid as a biomarker for the prognosis of acute stroke have found conflicting results. Methods: We collected blood samples from 600 consecutively admitted patients at our tertiary hospital and analysed the relationship between uric acid levels and functional prognosis (measured using the modified Rankin Scale [mRS]). Patients who had received reperfusion therapy were excluded since this may have influenced uric acid levels. Results: A total of 73% of patients had mRS scores <= 2; the mean uric acid level was 5.22 mg/dL. We found a nonlinear relationship between functional prognosis at discharge and serum uric acid levels at admission when the National Institutes of Health Stroke Scale score was excluded from the analysis. Conclusions: Serum uric acid levels in patients with acute ischaemic stroke are significantly associated with functional prognosis at discharge, although this relationship is nonlinear. In fact, poorer prognosis is associated both with very low and with very high concentrations of uric acid. This suggests a dual role of uric acid in relation to stroke: on the one hand, as an associated risk factor, and on the other, as a possible neuroprotective factor due to its antioxidant effect. (C) 2018 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 40 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke
    Amaro, Sergio
    Soy, Dolors
    Obach, Victor
    Cervera, Alvaro
    Planas, Anna M.
    Chamorro, Angel
    [J]. STROKE, 2007, 38 (07) : 2173 - 2175
  • [3] Uric Acid Levels Are Relevant in Patients With Stroke Treated With Thrombolysis
    Amaro, Sergio
    Urra, Xabier
    Gomez-Choco, Manuel
    Obach, Victor
    Cervera, Alvaro
    Vargas, Martha
    Torres, Ferran
    Rios, Jose
    Planas, Anna M.
    Chamorro, Angel
    [J]. STROKE, 2011, 42 (01) : S28 - S32
  • [4] The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4•5 h of onset of symptoms
    Amaro, Sergio
    Canovas, David
    Castellanos, Mar
    Gallego, Jaime
    Marti-Fabregas, Joan
    Segura, Tomas
    Chamorro, Angel
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2010, 5 (04) : 325 - 328
  • [5] [Anonymous], 2014, R LANG ENV STAT COMP
  • [6] Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials - A literature review and synthesis
    Banks, Jamie L.
    Marotta, Charles A.
    [J]. STROKE, 2007, 38 (03) : 1091 - 1096
  • [7] The complexity of neurobiological processes in acute ischemic stroke
    Brouns, R.
    De Deyn, P. P.
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (06) : 483 - 495
  • [8] Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome
    Brouns, Raf
    Wauters, Annick
    Van De Vijver, Gerda
    De Surgeloose, Didier
    Sheorajpanday, Rishi
    De Deyn, Peter P.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (03) : 383 - 390
  • [9] Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke
    Chamorro, A
    Obach, V
    Cervera, A
    Revilla, M
    Deulofeu, R
    Aponte, JH
    [J]. STROKE, 2002, 33 (04) : 1048 - 1052
  • [10] Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 213/3 trial
    Chamorro, Angel
    Amaro, Sergio
    Castellanos, Mar
    Segura, Tomas
    Arenillas, Juan
    Marti-Fabregas, Joan
    Gallego, Jaime
    Krupinski, Jurek
    Gomis, Meritxell
    Canovas, David
    Carne, Xavier
    Deulofeu, Ramon
    San Roman, Luis
    Oleaga, Laura
    Torres, Ferran
    Planas, Anna M.
    [J]. LANCET NEUROLOGY, 2014, 13 (05) : 453 - 460